To assess the effects of chemotherapy regimens containing capecitabine compared with regimens not containing capecitabine for women with ER-positive versus ER-negative breast cancer.
This is a protocol.
To assess the effects of chemotherapy regimens containing capecitabine compared with regimens not containing capecitabine for women with ER-positive versus ER-negative breast cancer.
This is a protocol.